| 期 |
标题 |
文件 |
| 卷 31, 编号 14 (2024) |
MicroRNA-mediated Regulation of LDL Receptor: Biological and Pharmacological Implications |
(Eng)
|
|
Keshavarz R., Reiner ., Zengin G., Eid A., Sahebkar A.
|
| 卷 31, 编号 22 (2024) |
miR-204-5p Plays a Critical Role in the Pathogenesis of Depression and Anti-depression Action of Venlafaxine in the Hippocampus of Mice |
(Eng)
|
|
Guan W., Wu X., Jin X., Sheng X., Fan Y.
|
| 卷 31, 编号 18 (2024) |
miR-26a is a Key Therapeutic Target with Enormous Potential in the Diagnosis and Prognosis of Human Disease |
(Eng)
|
|
Guan W., Chen Y., Fan Y.
|
| 卷 31, 编号 6 (2024) |
Mitapivat: A Novel Treatment of Hemolytic Anemia in Adults with Pyruvate Kinase Deficiency |
(Eng)
|
|
De S.
|
| 卷 31, 编号 19 (2024) |
Modulation of the HIF-1α-NCOA4-FTH1 Signaling Axis Regulating Ferroptosis-induced Hepatic Stellate Cell Senescence to Explore the Anti-hepatic Fibrosis Mechanism of Curcumol |
(Eng)
|
|
Zheng Y., Wang L., Wang J., Zhao T., Wang J.
|
| 卷 31, 编号 32 (2024) |
Modulatory Role of Phytochemicals/Natural Products in Cancer Immunotherapy |
(Eng)
|
|
Vijayan Y., Sandhu J., Harikumar K.
|
| 卷 31, 编号 20 (2024) |
Molecular Mechanism of Tau Misfolding and Aggregation: Insights from Molecular Dynamics Simulation |
(Eng)
|
|
Zhong H., Liu H., Liu H.
|
| 卷 31, 编号 36 (2024) |
Molecular Mechanisms and Therapeutic Potential of Resolvins in Cancer - Current Status and Perspectives |
(Eng)
|
|
Tajbakhsh A., Yousefi F., Farahani N., Savardashtaki A., Reiner ., Jamialahmadi T., Sahebkar A.
|
| 卷 31, 编号 34 (2024) |
Molecular Subtypes and Prognostic Models for Predicting Prognosis of Lung Adenocarcinoma based on MiRNA-related Genes |
(Eng)
|
|
Wei Y., Zhong W., Bi Y., Liu X., Zhou Q., Liu J., Wang M., Zhang H., Chen M.
|
| 卷 31, 编号 19 (2024) |
Multimodality Cardiac Imaging Biomarkers and Atrial Fibrillation Substrate: Are they Worthwhile? |
(Eng)
|
|
Androulakis E., Ahsan S., Papageorgiou N.
|
| 卷 31, 编号 25 (2024) |
Multiomics Analysis of Disulfidptosis Patterns and Integrated Machine Learning to Predict Immunotherapy Response in Lung Adenocarcinoma |
(Eng)
|
|
Liu J., Li H., Zhang N., Dong Q., Liang Z.
|
| 卷 31, 编号 40 (2024) |
Multi-omics Combined with Machine Learning Facilitating the Diagnosis of Gastric Cancer |
(Eng)
|
|
Li J., Xu S., Zhu F., Shen F., Zhang T., Wan X., Gong S., Liang G., Zhou Y.
|
| 卷 31, 编号 38 (2024) |
Multi-omics Data Integration Analysis Identified Therapeutic Targets and Potential Reuse Drugs for Osteoporosis |
(Eng)
|
|
Li M., Gao X., Zhang Y., Wang J., Dong R., Li P., He Y.
|
| 卷 31, 编号 13 (2024) |
Multiple Natural Polymers in Drug and Gene Delivery Systems |
(Eng)
|
|
Jiang Z., Song Z., Cao C., Yan M., Liu Z., Cheng X., Wang H., Wang Q., Liu H., Chen S.
|
| 卷 31, 编号 22 (2024) |
Multiple Protein Biomarkers and Different Treatment Strategies for Colorectal Carcinoma: A Comprehensive Prospective |
(Eng)
|
|
Chakraborty B., Agarwal S., Kori S., Das R., Kashaw V., Iyer A., Kashaw S.
|
| 卷 31, 编号 29 (2024) |
Mycobacterial Targets for Thiourea Derivatives: Opportunities for Virtual Screening in Tuberculosis Drug Discovery |
(Eng)
|
|
de Melo Milani V., Silva M., Camargo P., de Lima Ferreira Bispo M.
|
| 卷 31, 编号 28 (2024) |
Nanomedicine: Innovative Strategies and Recent Advances in Targeted Cancer Therapy |
(Eng)
|
|
Gautam R., Mittal P., Goyal R., Dua K., Mishra D., Sharma S., Singla R.
|
| 卷 31, 编号 7 (2024) |
Natural Anticancer Agents: Their Therapeutic Potential, Challenges and Promising Outcomes |
(Eng)
|
|
Tauro S., Dhokchawle B., Mohite P., Nahar D., Nadar S., Coutinho E.
|
| 卷 31, 编号 7 (2024) |
Natural Coumarin Derivatives Targeting Melanoma |
(Eng)
|
|
Silva L., Nunes J., Zhan P., Łączkowski K., Cardoso S., da Silva-Júnior E.
|
| 卷 31, 编号 26 (2024) |
Natural Phenolic Compounds with Antithrombotic and Antiplatelet Effects: A Drug-likeness Approach |
(Eng)
|
|
Fernandes D., Gomes A., da Silva C., de Medeiros Henriques I., de Menezes R., Scotti M., Teles Y., Edrada-Ebel R., de Fatima Vanderlei de Souza M.
|
| 卷 31, 编号 31 (2024) |
Natural Plant Materials as a Source of Neuroprotective Peptides |
(Eng)
|
|
Skibska A., Perlikowska R.
|
| 卷 31, 编号 31 (2024) |
Natural Products in Liver Fibrosis Management: A Five-year Review |
(Eng)
|
|
Wang T., Lu Z., Sun G., He K., Chen Z., Qu X., Han X.
|
| 卷 31, 编号 1 (2024) |
Naturally Occurring Xanthones; Biological Activities, Chemical Profiles and In Silico Drug Discovery |
(Eng)
|
|
El-Seedi H., Ibrahim H., Yosri N., Ibrahim M., Hegazy M., Setzer W., Guo Z., Zou X., Refaey M., Salem S., Musharraf S., Saeed A., Salem S., Xu B., Zhao C., Khalifa S.
|
| 卷 31, 编号 32 (2024) |
Natures Elixir for Cancer Treatment: Targeting Tumor-induced Neovascularization |
(Eng)
|
|
Kumari R., Syeda S., Shrivastava A.
|
| 卷 31, 编号 38 (2024) |
Neuroprotective Effect of Natural Indole and β-carboline Alkaloids against Parkinsons Disease: An Overview |
(Eng)
|
|
Shome A., Chahat ., Chawla V., Chawla P.
|
| 卷 31, 编号 23 (2024) |
Neuroprotective Properties of Antiepileptics: What are the Implications for Psychiatric Disorders? |
(Eng)
|
|
Dell'Osso L., Nardi B., Massoni L., Gravina D., Benedetti F., Cremone I., Carpita B.
|
| 卷 31, 编号 20 (2024) |
Neurosteroids and their Therapeutic Potential: Remembering the Contribution of Dr. Sabina Luchetti, Netherlands Institute for Neuroscience, Amsterdam, Netherlands |
(Eng)
|
|
di Michele F.
|
| 卷 31, 编号 11 (2024) |
New Insights into the Long Non-coding RNAs Dependent Modulation of Heart Failure and Cardiac Hypertrophy: From Molecular Function to Diagnosis and Treatment |
(Eng)
|
|
Rezaee M., Masihipour N., Milasi Y., Dehmordi R., Reiner ., Asadi S., Mohammadi F., Khalilzadeh P., Rostami M., Asemi Z., Mafi A.
|
| 卷 31, 编号 21 (2024) |
New Molecules of Importance in the Prevention and Treatment of Acne: A Systematic Patent Review (2016-2020) |
(Eng)
|
|
Calderón-Pardo D., Serafini M., Alves I., Aragón D.
|
| 卷 31, 编号 33 (2024) |
New Pyrrolopyrimidines as LRRK2 Inhibitors for Treating Parkinson's Disease |
(Eng)
|
|
De S.
|
| 卷 31, 编号 9 (2024) |
NLS-3 (Levophacetoperane or (R,R) Phacetoperane): A Reverse Ester of Methylphenidate: A Literature Review |
(Eng)
|
|
Konofal E., Lecendreux M., Bizot J., Lormier A., Figadère B.
|
| 卷 31, 编号 29 (2024) |
N-Methyl-D-Aspartate (NMDA) Receptor Antagonists and their Pharmacological Implication: A Medicinal Chemistry-oriented Perspective Outline |
(Eng)
|
|
Rana V., Ghosh S., Bhatt A., Bisht D., Joshi G., Purohit P.
|
| 卷 31, 编号 34 (2024) |
Non-oxidative Modified Low-density Lipoproteins: The Underappreciated Risk Factors for Atherosclerosis |
(Eng)
|
|
Zhao Y., Xu Q., He N., Jiang M., Chen Y., Ren Z., Tang Z., Wu C., Liu L.
|
| 卷 31, 编号 17 (2024) |
Non-oxidative vs Oxidative Forms of Modified Low-density Lipoprotein: What is More Important in Atherogenesis? |
(Eng)
|
|
Orekhov A., Khotina V., Sukhorukov V., Sobenin I.
|
| 卷 31, 编号 28 (2024) |
Novel Adiponectin Receptor Agonist Inhibits Cholangiocarcinoma via Adenosine Monophosphate-activated Protein Kinase |
(Eng)
|
|
Bui K., Nguyen T., Barat S., Scholta T., Xing J., Bhuria V., Sipos B., Wilkens L., Nguyen L., Le H., Velavan T., Bozko P., Plentz R.
|
| 卷 31, 编号 5 (2024) |
Novel and Latest Computational Routes in the Design and Development of Anticancer Drugs |
(Eng)
|
|
Kamal M., Akhtar S.
|
| 卷 31, 编号 40 (2024) |
Novel Anti-tumor Bio-drugs and Therapeutic Strategies in Cancer Management: From Bench to Translational Research |
(Eng)
|
|
Huang S.
|
| 卷 31, 编号 5 (2024) |
Novel Computational Methods for Cancer Drug Design |
(Eng)
|
|
Talluri S., Kamal M., Malla R.
|
| 卷 31, 编号 40 (2024) |
Novel Natural Inhibitors for Glioblastoma by Targeting Epidermal Growth Factor Receptor and Phosphoinositide 3-kinase |
(Eng)
|
|
Ullah A., Ullah S., Waqas M., Khan M., Rehman N., Khalid A., Jan A., Aziz S., Naeem M., Halim S., Khan A., Al-Harrasi A.
|
| 卷 31, 编号 4 (2024) |
Novel Perspectives for the Diagnosis and Treatment of Gynecological Cancers using Dysregulation of PIWI Protein and PiRNAs as Biomarkers |
(Eng)
|
|
Yousefi B., Sadoughi F., Asemi Z., Mansournia M., Hallajzadeh J.
|
| 卷 31, 编号 34 (2024) |
Novel Pyrazino[2,3-b] Pyrazines as mTOR Kinase Inhibitors for Treating Cancer and other Diseases |
(Eng)
|
|
De S.
|
| 卷 31, 编号 8 (2024) |
Novel Pyrimidin-4-yl-3-amino-pyrrolo[3,4-c]pyrazoles as Protein Kinase C Inhibitors for Treating Diseases |
(Eng)
|
|
De S.
|
| 卷 31, 编号 3 (2024) |
Novel Synthesized Tyrosinase Inhibitors: A Systematic Patent Review (2012-Present) |
(Eng)
|
|
Beltran E., Serafini M., Alves I., Aragón Novoa D.
|
| 卷 31, 编号 35 (2024) |
Nucleoside Scaffolds and Carborane Clusters for Boron Neutron Capture Therapy: Developments and Future Perspective |
(Eng)
|
|
Khalil A., Adam M.
|
| 卷 31, 编号 10 (2024) |
Oxocarbon Acids and their Derivatives in Biological and Medicinal Chemistry |
(Eng)
|
|
Ratto A., Honek J.
|
| 卷 31, 编号 9 (2024) |
PAFAH1B3 Regulates Papillary Thyroid Carcinoma Cell Proliferation and Metastasis by Affecting the EMT |
(Eng)
|
|
Jiang W., Quan R., Bhandari A., Hirachan S., Chen C., Lv S., Zheng C.
|
| 卷 31, 编号 22 (2024) |
PaSTe. Blockade of the Lipid Phenotype of Prostate Cancer as Metabolic Therapy: A Theoretical Proposal |
(Eng)
|
|
Romo-Perez A., Domínguez-Gómez G., Chávez-Blanco A., González-Fierro A., Correa-Basurto J., Dueñas-González A.
|
| 卷 31, 编号 1 (2024) |
PBPK Modeling as an Alternative Method of Interspecies Extrapolation that Reduces the Use of Animals: A Systematic Review |
(Eng)
|
|
Lancheros Porras K., Alves I., Novoa D.
|
| 卷 31, 编号 11 (2024) |
Peptide Amphiphiles for Pharmaceutical Applications |
(Eng)
|
|
Fuertes-Llanos M., Gómara M., Haro I., Sánchez-López E.
|
| 卷 31, 编号 2 (2024) |
Peptide-based PROTACs: Current Challenges and Future Perspectives |
(Eng)
|
|
Wang H., Chen M., Zhang X., Xie S., Qin J., Li J.
|
| 卷 31, 编号 10 (2024) |
Percutaneous Coronary Intervention Associated with a Higher Risk of Hypoxemia and COVID-19 Severity |
(Eng)
|
|
Shayan S., Nasrollahi E., Bahramvand Y., Zarei M., Atarodi A., Farsi Y., Tavakolizadeh M., Shirvaliloo M., Abbasifard M., Jamialahmadi T., Banach M., Sahebkar A.
|
| 卷 31, 编号 22 (2024) |
Performance of Green Desymmetrization Methods toward Bioactive Cephalostatin Analogues |
(Eng)
|
|
Nawasreh M., Tahtamouni L.
|
| 卷 31, 编号 42 (2024) |
Perillyl Alcohol Promotes Relaxation in Human Umbilical Artery |
(Eng)
|
|
de Sena Bastos C., Pereira-de-Morais L., de Alencar Silva A., de Menezes Dantas D., Batista P., Gomes M., de Araújo Delmondes G., de Menezes I., da Silva R., Barbosa R.
|
| 卷 31, 编号 41 (2024) |
Periodontitis Continuum: Antecedents, Triggers, Mediators, and Treatment Strategies |
(Eng)
|
|
Gasmi Benahmed A., Tippairote T., Gasmi A., Noor S., Avdeev O., Shanaida Y., Mojgani N., Emadali A., Dadar M., Bjørklund G.
|
| 卷 31, 编号 8 (2024) |
Perspective and Prospects on Persistent Luminescent Nanoparticles for Biological Imaging and Tumor Therapy |
(Eng)
|
|
Sun M., Chen M., Wang J.
|
| 卷 31, 编号 3 (2024) |
Perspectives and Prospects on the Application of DNA Aptamer in SARS-CoV-2 |
(Eng)
|
|
Liu Y., Hu B., Li J., Pei X., Hu X.
|
| 卷 31, 编号 12 (2024) |
Perspectives on Iron Deficiency as a Cause of Human Disease in Global Public Health |
(Eng)
|
|
Bjørklund G., Semenova Y., Hangan T., Pen J., Aaseth J., Peana M.
|
| 卷 31, 编号 22 (2024) |
Pharmacokinetics of Anti-rheumatic Drugs Methotrexate and Tofacitinib with its Metabolite M9 in Rats by UPLC-MS/MS |
(Eng)
|
|
Gu E., Xue L., Zhou C., Xia Y., Dai G.
|
| 卷 31, 编号 5 (2024) |
Pharmacophore & QSAR Guided Design, Synthesis, Pharmacokinetics and In vitro Evaluation of Curcumin Analogs for Anticancer Activity |
(Eng)
|
|
Alam S., Verma S., Fatima K., Luqman S., Srivastava S., Khan F.
|
| 卷 31, 编号 3 (2024) |
Phosphate Prodrugs: An Approach to Improve the Bioavailability of Clinically Approved Drugs |
(Eng)
|
|
Tantra T., Singh Y., Patekar R., Kulkarni S., Kumar P., Thareja S.
|
| 卷 31, 编号 32 (2024) |
Phytochemicals as Potential Lead Molecules against Hepatocellular Carcinoma |
(Eng)
|
|
Rayginia T., Keerthana C., Shifana S., Pellissery M., Abhishek A., Anto R.
|
| 卷 31, 编号 34 (2024) |
Phytochemicals as Substances that Affect Astrogliosis and their Implications for the Management of Neurodegenerative Diseases |
(Eng)
|
|
Forouzanfar F., Pourbagher-Shahri A., Vafaee F., Sathyapalan T., Sahebkar A.
|
| 卷 31, 编号 32 (2024) |
Phytochemicals as Therapeutic Agents against Cancer |
(Eng)
|
|
Bharti A.
|
| 卷 31, 编号 30 (2024) |
Pirtobrutinib: First Non-covalent Tyrosine Kinase Inhibitor for Treating Relapsed or Refractory Mantle Cell Lymphoma in Adults |
(Eng)
|
|
De S.
|
| 卷 31, 编号 39 (2024) |
PLGA Nanoparticles as New Drug Delivery Systems in Leishmaniasis Chemotherapy: A Review of Current Practices |
(Eng)
|
|
Valiallahi A., Vazifeh Z., Gatabi Z., Davoudi M., Gatabi I.
|
| 卷 31, 编号 37 (2024) |
Polyphenolic Nano-formulations: A New Avenue against Bacterial Infection |
(Eng)
|
|
Farhadi F., Eghbali S., Torabi Parizi S., Jamialahmadi T., Gumpricht E., Sahebkar A.
|
| 卷 31, 编号 42 (2024) |
Porphyrinuria in Autism Spectrum Disorder: A Review |
(Eng)
|
|
Bjørklund G., Semenova Y., El-Ansary A., Al-Ayadhi L.
|
| 卷 31, 编号 22 (2024) |
Potential Drugs in COVID-19 Management |
(Eng)
|
|
Gasmi A., Noor S., Menzel A., Khanyk N., Semenova Y., Lysiuk R., Beley N., Bolibrukh L., Gasmi Benahmed A., Storchylo O., Bjørklund G.
|
| 卷 31, 编号 19 (2024) |
Potential Role of Bone Metabolism Markers in Kidney Transplant Recipients |
(Eng)
|
|
Vigil F., Castro P., Hasparyk U., Bartolomei V., Silva A.
|
| 卷 31, 编号 21 (2024) |
Potential Therapeutic Targets for the Management of Diabetes Mellitus Type 2 |
(Eng)
|
|
Prabhakar P., Batiha G.
|
| 卷 31, 编号 26 (2024) |
Prediction Model for Therapeutic Responses in Ovarian Cancer Patients using Paclitaxel-resistant Immune-related lncRNAs |
(Eng)
|
|
Li X., Liu H., Wang F., Yuan J., Guan W., Xu G.
|
| 卷 31, 编号 31 (2024) |
Prediction of Human Microbe-Drug Association based on Layer Attention Graph Convolutional Network |
(Eng)
|
|
Qu J., Ni J., Ni T., Bian Z., Liang J.
|
| 卷 31, 编号 36 (2024) |
Predictive Analysis of Yi-Gai-San's Multifaceted Mechanisms for Tremor-dominant Parkinson's Disease via Network Pharmacology and Molecular Docking Validation |
(Eng)
|
|
Lin C., Wu L., Tsai F.
|
| 卷 31, 编号 1 (2024) |
Preface |
(Eng)
|
|
Atta-ur-Rahman .
|
| 卷 31, 编号 30 (2024) |
Probiotics for Inflammatory Bowel Disease; A Deep Dive into their Impact on Disease Course and Associated Health Risks |
(Eng)
|
|
Hassan W., Al-kaabi M., Akram N., Kassim M., Pantazi A.
|
| 卷 31, 编号 7 (2024) |
Prof. Dr. Ferid Murad (Nobel Laureate), a Great Friend of Bentham Science, Dies at the Age of 86 |
(Eng)
|
|
|
| 卷 31, 编号 42 (2024) |
Prognostic Value and Therapeutic Significance of CCL Chemokines in Gastric Cancer |
(Eng)
|
|
Tian Y., Xie Y., Yi G., Wu F., Dang X., Bai F., Wang J., Zhang D.
|
| 卷 31, 编号 29 (2024) |
Promises and Pitfalls of Calcineurin Inhibitors in COVID-19: A Systematic Review and Meta-analysis of Controlled Trials |
(Eng)
|
|
Heydari B., Sahebnasagh A., Omrani M., Azimi S., Dehghani M., Salehi-Abargouei A., Farman F., Saghafi F.
|
| 卷 31, 编号 25 (2024) |
Protective Effects of Curcumin and its Analogues via the Nrf2 Pathway in Metabolic Syndrome |
(Eng)
|
|
Rajabi S., Darroudi M., Naseri K., Farkhondeh T., Samarghandian S.
|
| 卷 31, 编号 24 (2024) |
Protective Roles and Therapeutic Effects of Gallic Acid in the Treatment of Cardiovascular Diseases: Current Trends and Future Directions |
(Eng)
|
|
Momeni Z., Danesh S., Ahmadpour M., Eshraghi R., Farkhondeh T., Pourhanifeh M., Samarghandian S.
|
| 卷 31, 编号 3 (2024) |
Protein Folding and Molecular Basis of Memory: Molecular Vibrations and Quantum Entanglement as Basis of Consciousness |
(Eng)
|
|
Atta-ur-Rahman .
|
| 卷 31, 编号 6 (2024) |
Purine Nucleosides and Analogues Bearing Chiral Substituents: Medicinal Chemistry and Therapeutic Perspective |
(Eng)
|
|
Drenichev M., Borokh V.
|
| 卷 31, 编号 8 (2024) |
Pyrazolo[4,3-H]quinazolines as Cyclin-dependent Kinase Inhibitors for Treating Cancer |
(Eng)
|
|
De S.
|
| 卷 31, 编号 36 (2024) |
Pyrrolo[2,3-D]Pyrimidines as EGFR and VEGFR Kinase Inhibitors: A Comprehensive SAR Review |
(Eng)
|
|
Metwally K., Abo-Dya N.
|
| 卷 31, 编号 40 (2024) |
Quantitative Structure-activity Relationship (QSAR) Modelling of Indomethacin Derivatives using Regression Analysis |
(Eng)
|
|
Shukla N., Sharma B.
|
| 卷 31, 编号 33 (2024) |
Radiotherapy-associated Sensorineural Hearing Loss in Pediatric Oncology Patients |
(Eng)
|
|
Aslam M., Ahmad H., Malik H., Uinarni H., Karim Y., Akhmedov Y., Abdelbasset W., Awadh S., Abid M., Mustafa Y., Farhood B., Sahebkar A.
|
| 卷 31, 编号 37 (2024) |
Recent Advancements in the Treatment of Alzheimers Disease: A Multitarget-directed Ligand Approach |
(Eng)
|
|
Kumar S., Mahajan A., Ambatwar R., Khatik G.
|
| 卷 31, 编号 4 (2024) |
Recent Advances and Techniques for Identifying Novel Antibacterial Targets |
(Eng)
|
|
Qiu J., Tang Z., He Y., Nazli A.
|
| 卷 31, 编号 26 (2024) |
Recent Advances in Protein Folding Pathway Prediction through Computational Methods |
(Eng)
|
|
Zhao K., Liang F., Xia Y., Hou M., Zhang G.
|
| 卷 31, 编号 18 (2024) |
Recent Advances in Research on Active Compounds Against Hepatic Fibrosis |
(Eng)
|
|
Liu C., Li S., Zhang C., Jin C.
|
| 卷 31, 编号 37 (2024) |
Recent Advances in the Synthesis and Analysis of Atorvastatin and its Intermediates |
(Eng)
|
|
Li S., Zhang W., Zhang W., Huang A., Zhu J., Wang Y., Zheng Y.
|
| 卷 31, 编号 20 (2024) |
Recent Advances on PKM2 Inhibitors and Activators in Cancer Applications |
(Eng)
|
|
Chen P., Lou L., Sharma B., Li M., Xie C., Yang F., Wu Y., Xiao Q., Gao L.
|
| 卷 31, 编号 17 (2024) |
Recent Advances on the Antimicrobial Activities of Schiff Bases and their Metal Complexes: An Updated Overview |
(Eng)
|
|
Jorge J., Del Pino Santos K., Timóteo F., Piva Vasconcelos R., Ignacio Ayala Cáceres O., Juliane Arantes Granja I., de Souza D., Allievi Frizon T., Di Vaccari Botteselle G., Luiz Braga A., Saba S., Rashid H., Rafique J.
|
| 卷 31, 编号 35 (2024) |
Recent Developments in Coumarin Derivatives as Neuroprotective Agents |
(Eng)
|
|
Mishra P., Kumar A., Kaur K., Jaitak V.
|
| 卷 31, 编号 10 (2024) |
Recent Discovery of Peptidomimetics for the Treatment of Coronavirus (COVID-19), Human Coronavirus, and Enteroviruses |
(Eng)
|
|
De S.
|
| 卷 31, 编号 30 (2024) |
Recent Update on the Protective Potentials of Resveratrol against Cisplatin-induced Ototoxicity: A Systematic Review |
(Eng)
|
|
Alsaikhan F., Jasim S., Margiana R., Opulencia M., Yasin G., Hammid A., Nasretdinova M., Mahdi A., Farhood B., Abedi-Firouzjah R., Jamialahmadi T., Sahebkar A.
|
| 卷 31, 编号 25 (2024) |
Recent Updates on Interaction Studies and Drug Delivery of Antimalarials with Serum Albumin Proteins |
(Eng)
|
|
Azeem K., Irfan I., Rashid Q., Singh S., Patel R., Abid M.
|
| 卷 31, 编号 23 (2024) |
Recent Updates on Oncogenic Signaling of Aurora Kinases in Chemosensitive, Chemoresistant Cancers: Novel Medicinal Chemistry Approaches for Targeting Aurora Kinases |
(Eng)
|
|
Kumari P., Beeraka N., Tengli A., Bannimath G., Baath R., Patil M.
|
| 卷 31, 编号 34 (2024) |
Regulatory Non-coding RNAs Involved in Oxidative Stress and Neuroinflammation: An Intriguing Crosstalk in Parkinsons Disease |
(Eng)
|
|
Khish N., Ghiasizadeh P., Rasti A., Moghimi O., Zadeh A., Bahiraee A., Ebrahimi R.
|
| 卷 31, 编号 24 (2024) |
Research Progress in Estrogen-related Receptor Gamma (ERRγ) Agonists and Inverse Agonists |
(Eng)
|
|
Zheng Y., Du Y., Zhang H., Lv H., Yan Z., Dong N., Li Q., Wang T.
|
| 201 - 300 的 400 信息 |
<< < 1 2 3 4 > >> |
